Telomir Pharmaceuticals Inc. logo

Telomir Pharmaceuticals Inc. (TELO)

Market Open
12 Jun, 13:52
NASDAQ (CM) NASDAQ (CM)
$
1. 25
-0.01
-0.754%
$
43.66M Market Cap
- P/E Ratio
- Div Yield
3,935 Volume
- Eps
$ 1.26
Previous Close
Investors:
Add Transaction
Day Range
1.25 1.27
Year Range
1.05 3.1
Want to track TELO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Telomir Pharmaceuticals Inc. (TELO) Statistics

Valuation metrics

Market Cap 43.66M
Enterprise value 36.04M
Trailing P/E (ttm) -4.51
Forward P/E -
PEG ratio -0.26
Price/Sales (ttm) -
Price/Book (mrq) 8.38
Enterprise Value/Revenue -
Enterprise Value/EBITDA -3.89

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 80.26K
Average volume (90 days) 137.89K

Price summary

52-Week low 1.05
52-Week high 3.1
Beta -
50-Day moving average 1.33
200-Day moving average 1.31

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin -
Operating margin -

Operational effectiveness

Return on assets -1.59%
Return on equity -2.01%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.27
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 0.16
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 7%
Book value per share (mrq) 0.14

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -